BY ALBERT RONNING-ANDERSSON
-
Milestone payments are uncertain in life sciences: Only 9.5% are paid out
Due to the substantial unpredictability bordering landmark settlements, Danish life scientific research funds are dealing with difficult to protect the biggest feasible in advance …
-
Evaxion CEO calls MSD rejection “disappointing, unfortunate, and surprising”
MSD will certainly not exercise its choice on the Danish firm’s gonorrhea injection prospect, indicating that Evaxion will certainly need to wait a very long time for prospec…
-
Abbvie acquires cancer drug candidate for USD 100m
The United States business started 2025 with a sell China and finished the year with one more.
-
ALK criticizes committee proposal to remove subsidies in favor of competing product
ALK says that Grazax has a tested lasting impact that its rival’s item can not match, and ALK likewise indicates mistakes in the expense computations made by the Danish compe…
-
Japanese drugmaker acquires one of the few approved ALS drugs for USD 2.5bn
The procurement consists of both dental and intravenous types of the medication Radicava.
-
Danish-developed psoriasis treatment receives Canadian approval
MC2 Rehabs’ Canadian companion Knight Rehab has actually been okayed to market the psoriasis medication Wynzora in Canada.
-
Novo-company headed by Dane lands landmark deal in the US: “It’s with mixed feelings”
The Novo Holdings-owned biotech firm Orexo has actually offered the legal rights in the United States to its primary property, Zubsolv, for even more USD 91 million
-
Novo-company headed by Dane lands landmark deal in the US: “It’s with mixed feelings”
The Novo Holdings-owned biotech company Orexo has sold the rights in the US to its main asset, Zubsolv, for more USD 91 million
-
Danish-developed psoriasis treatment receives Canadian approval
MC2 Therapeutics’ Canadian partner Knight Therapeutics has been given the green light to sell the psoriasis drug Wynzora in Canada.
-
EU wants to make it easier to be an AI medtech business
As component of the European Payment’s draft modification of the medtech regulations, it is recommended that medtech business need to not need to adhere to the complicated AI…
